<h1 itemprop="aspect"> <strong>Xeljanz Side Effects</strong></h1><div class="thumbnail-div"> <img width="84" height="84" src="http://www.bad-drug.net/wp-content/uploads/2013/02/84x84xXeljanz-Pfizer-5mg-Tablets-Bottle-84x84.jpg,q1df917.pagespeed.ic.1L7fx8O7io.jpg" class="attachment-84x84 wp-post-image" alt="Xeljanz" title="Xeljanz"/></div><h2>Serious Adverse Side Effects</h2><ul><li>Gastrointestinal side effects such as perforation  of the gastrointestinal tract</li><li>Hematological side effects such as <a href="http:/en.wikipedia.org/wiki/Neutropenia" target="_blank" rel="nofollow">neutropenia</a>, an abnormally and dangerously low amount of neutrophils (certain type of white blood cells) in the blood</li><li>Hepatic side effects such as injury to the liver</li><li>Immunological side effects such as being susceptible to infections, post-transplant <a href="http:/en.wikipedia.org/wiki/Lymphoproliferative_disorders" target="_blank" rel="nofollow">lymphoproliferative disorder</a> (a disorder where lymphocytes (a kind of white blood cell) is produced in excessive quantities), and <a href="http:/en.wikipedia.org/wiki/Epstein%E2%80%93Barr_virus" target="_blank" rel="nofollow">Epstein-Barr virus</a>, a type of herpes complex virus</li><li>Other side effects such as cancer</li></ul><h2>Common Adverse Side Effects</h2><ul><li>Endocrine metabolic side effects such as increased high-density lipoprotein levels and raised low density lipoprotein cholesterol</li><li>Immunological side effects such as infectious diseases</li><li>Neurological side effects such as headache</li><li>Renal side effects such as urinary tract infectious disease</li><li>Respiratory side effects such as the cold and upper respiratory infections</li></ul></div><div class="v" id="tab2" ><h2 itemprop="aspect"> <strong> Warnings & Recalls for Xeljanz </strong></h2><h1>Black Box Warning</h1> <b>Xeljanz |</b> <b>Tofacitinib Citrate</b> has an associated “black box” warning attached to it that denotes that serious infections that often lead to hospitalization or death which can include TB, bacteria, invasive fungal, viral and other opportunistic infections, have occurred in patients receiving this drug.  If a serious infection develops, interrupt Xeljanz until the infection is controlled.  Prior to starting Xeljanz, a test should be performed for latent TB.  If the test is positive for TB, a treatment for treating the TB first should be initiated before going on a Xeljanz regimen.  The patient should be monitored for active TB during treatment, even if the initial TB test had resulted negatively. <br> <br> Lymphoma and other malignancies has been reported in patients who are treated with Xeljanz.  Epstein-Barr virus-associated post-transplant lymphoproliferative disorder has been reported at an increased rate in patients who undergo kidney transplants who are treated with this drug concurrently with other immunosuppressive medications.<h2>Contraindications</h2> Specific contraindications for Xeljanz have not yet been determined.<h2>Precautions</h2> Patients with the following preexisting conditions or warnings should take these precautionary measures or not consider taking <b>Xeljanz |</b> <b>Tofacitinib Citrate</b> at all:<ul><li>Patients with active infections</li><li>Patients with TB exposure or history of TB</li><li>Patients with known malignancies</li><li>Patients with hepatic impairments</li><li>Patients with renal impairments</li><li>Patients undertaking vaccines currently</li></ul><h2>Pregnancy Warning</h2> <b>Xeljanz |</b> <b>Tofacitinib Citrate</b> has been given a pregnancy category rating of “C” by the FDA, implying that it should be discontinued while pregnant due to posing a risk to both the expecting mother and her developing child.</div><div class="v" id="tab3" ><h2 itemprop="aspect"> <strong> Xeljanz Treatment and Use </strong></h2><div class="thumbnail-div"> <img width="84" height="84" src="http://www.bad-drug.net/wp-content/uploads/2013/02/84x84xXeljanz-Pfizer-5mg-Tablets-Bottle-84x84.jpg,q1df917.pagespeed.ic.1L7fx8O7io.jpg" class="attachment-84x84 wp-post-image" alt="Xeljanz" title="Xeljanz"/></div><p><b>Xeljanz |</b> <b>Tofacitinib Citrate </b>is a drug that’s manufactured and marketed by <a target="_blank" href="http:/www.pfizer.com/home/" target="_blank" rel="nofollow">Pfizer</a> prescribed specifically for the treatment of <a target="_blank" href="http:/www.ncbi.nlm.nih.gov/pubmedhealth/PMH0001467/" target="_blank" rel="nofollow">rheumatoid arthritis</a>.  It was approved by the FDA on November of 2012.  A pitfall of this drug is that many rheumatologists have complained that the <a target="_blank" href="http:/www.nature.com/nbt/journal/v31/n1/full/nbt0113-3.html" target="_blank" rel="nofollow">price-tag of $2,500</a> for a month of <b>Xeljanz |</b> <b>Tofacitinib Citrate</b> is just much too expensive.</p><p>Non-FDA labeled indications for this drug are for treating:</p><ul><li><a target="_blank" href="http:/en.wikipedia.org/wiki/Psoriasis" target="_blank" rel="nofollow">Psoriasis</a></li><li><a target="_blank" href="http:/en.wikipedia.org/wiki/Inflammatory_bowel_disease" target="_blank" rel="nofollow">Inflammatory bowel disease</a></li><li>For possible use in other immunological diseases</li><li>The prevention of organ transplant rejection</li></ul><p>Please refer to the “Warnings and Recalls” tab to get more information on <b>Xeljanz |</b> <b>Tofacitinib Citrate’s</b> “black box” warning.</p><h2>How This Drug Works</h2><p><b>Xeljanz |</b> <b>Tofacitinib Citrate</b> inhibits Janus kinases (JAK), or intracellular enzymes, and modulates a signaling pathway which influences the cellular processes of hematopoiesis and immune cellular function.  Signals from this pathway arise from cytokine or growth factor-receptor interactions on cellular membranes.  Inhibition of JAK prevents many of the complications that arise from rheumatoid arthritis and other immunological diseases.</p><h2>Dosage Information</h2><p>The safety and the efficacy of using <b>Xeljanz |</b> <b>Tofacitinib Citrate</b> on pediatric patients has not been established as of yet.  The following is the adult dosing of <b>Xeljanz |</b> <b>Tofacitinib Citrate</b> for patients with rheumatoid arthritis:</p><ul><li>For adult patients with rheumatoid arthritis (moderate to severe): 5mg ORALLY twice daily</li></ul></div><div class="v" id="tab4" ><h2 itemprop="aspect"> Other Names for Xeljanz</h2><h2>Brand Name</h2><br/><ul><br/><li>Xeljanz</li><br/></ul><br/><h2>Generic Name</h2><br/><ul><br/><li>Tofacitinib Citrate</li><br/></ul></div><div class="v" id="tab5" ><h2 itemprop="aspect"> <strong> Lawsuits & Legal Information for Xeljanz </strong></h2>